Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aardvark Therapeutics Inc...

    NASDAQ: AARD · Real-Time Price · USD
    11.86
    -0.09 (-0.75%)
    At close: Jun 06, 2025, 3:59 PM
    11.81
    -0.42%
    After-hours: Jun 06, 2025, 04:04 PM EDT

    Aardvark Therapeutics Common Stock Statistics

    Share Statistics

    Aardvark Therapeutics Common Stock has 21.7M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 21.7M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 208

    FTD / Avg. Volume

    n/a
    		 0.22%

    Short Selling Information

    The latest short interest is 344.31K, so 1.59% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 344.31K

    Short % of Shares Out

    n/a
    		 1.59%

    Short % of Float

    n/a
    		 2.44%

    Short Ratio (days to cover)

    n/a
    		 4.07

    Valuation Ratios

    The PE ratio is -8.97 and the forward PE ratio is -4.69. Aardvark Therapeutics Common Stock's PEG ratio is -0.05.

    PE Ratio

    n/a
    		 -8.97

    Forward PE

    n/a
    		 -4.69

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 2.56

    P/FCF Ratio

    n/a
    		 -10.15

    PEG Ratio

    n/a
    		 -0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Aardvark Therapeutics Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 15.05, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 15.05

    Quick Ratio

    n/a
    		 15.05

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-935,818.18

    Employee Count

    n/a
    		 22

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 2.27, so Aardvark Therapeutics Common Stock's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.27

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 9.47

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 61.24

    Average Volume (20 Days)

    n/a
    		 93,265

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -22.79M

    Net Income

    n/a
    		 -20.59M

    EBITDA

    n/a
    		 -22.79M

    EBIT

    n/a
    		 -22.67M

    Earnings Per Share (EPS)

    n/a
    		 -1.59
    Full Income Statement

    Balance Sheet

    The company has 61.64M in cash and 779K in debt, giving a net cash position of 60.86M.

    Cash & Cash Equivalents

    n/a
    		 61.64M

    Total Debt

    n/a
    		 779K

    Net Cash

    n/a
    		 60.86M

    Retained Earnings

    n/a
    		 -58.33M

    Total Assets

    n/a
    		 157.03M

    Working Capital

    n/a
    		 148.58M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -18.09M and capital expenditures -109K, giving a free cash flow of -18.2M.

    Operating Cash Flow

    n/a
    		 -18.09M

    Capital Expenditures

    n/a
    		 -109K

    Free Cash Flow

    n/a
    		 -18.2M

    FCF Per Share

    n/a
    		 -1.41
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    AARD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for AARD is $26, which is 117.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $26

    Price Target Difference

    n/a
    		 117.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 20.94

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist